James Gordon, MD
Pain Medicine · Monroe, LANPI 1528149820
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,774 of the $7,449 with a category attached, or 64.1%. 23 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 40.4% of the total. 2025 is the largest year on record at $3,556, more than ten times the $353 reported in 2019.
Across 135 payments — averaging $55.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$3K
- Boston Scientific$1K
- Camber Spine Technologies LLC$634
- Surgentec$481
- Nevro Corp.$348
- Amgen$300
- plus $1K from 17 others
What the payments were for
- Travel & lodging$2,67536%
- Food & beverage$4,77464%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 15 | $3,007 |
| Boston Scientific | 39 | $1,308 |
| Camber Spine Technologies LLC | 2 | $634 |
| Surgentec | 1 | $481 |
| Nevro Corp. | 14 | $348 |
| Amgen | 18 | $300 |
| Alcon | 2 | $293 |
| Stryker | 3 | $228 |
| Vertos Medical, Inc. | 5 | $216 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $140 |
| Abbott | 4 | $95 |
| Medtronic(2 entities) | 5 | $74 |
| Curonix LLC | 3 | $58 |
| AbbVie | 3 | $44 |
| Collegium Pharmaceutical, Inc. | 3 | $44 |
| Relievant Medsystems, Inc. | 1 | $40 |
| Interventional Pain Technologies Inc. | 1 | $38 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Biotronik NRO, Inc. | 1 | $23 |
| Vertex | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $11 |
| Assertio Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$2,740
- Intracept$609
- ION Facet Screw System$481
- TiLink$481
- Rocklatan$147
How this compares
$7,449 in reported general payments places this provider in the 70th percentile of 97 pain medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 5,278 | $123,142 |
| OxycontinOxycodone Hcl | 53 | $48,433 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,504 | $41,846 |
| Gabapentin | 1,737 | $17,267 |
| Fentanyl | 168 | $15,442 |
| LinzessLinaclotide | 25 | $13,081 |
| MovantikNaloxegol Oxalate | 26 | $10,026 |
| Tramadol Hcl | 978 | $7,017 |
| Morphine Sulfate ErMorphine Sulfate | 195 | $6,043 |
| Pregabalin | 540 | $5,909 |
| Tizanidine Hcl | 809 | $5,093 |
| Diclofenac Sodium | 199 | $5,082 |
| Cyclobenzaprine Hcl | 602 | $4,365 |
| Oxycodone Hcl | 230 | $4,144 |
| Lidocaine | 28 | $3,024 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $44 | $13,08125 claims |
| Redhill Biopharma Inc.Movantik | $11 | $10,02626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 97 pain medicine providers in Louisiana.
Other pain medicine in Monroe
- Harold BayonneMonroe$6K
- Brandon BanksMonroe$6K
- Thomas MyersMandeville$118K
- Alan KayeNew Orleans$76K
- Derrick DeanTerrytown$68K
- Hazem EissaNew Orleans$50K
- Robert OwensNew Orleans$47K
- Gassan ChaibanLake Charles$30K
- Yashar EshraghiNew Orleans$22K
- Prathima AnandiShreveport$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.